Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial ( 5-9905 Investors: Amy Sullivan (617) ...)

(Date:11/6/2009)..., BOTHELL, Wash., Nov. 6 /PRNewswire-FirstCall/ -...financial results for the three and nine months en... SCOLR Pharma,s President and CEO, said, "We conti...r 12-hour ibuprofen formulation. Several potential...time, personnel and external resources as they eva...

(Date:11/6/2009)..., ,, FORT WASHINGTON, Pa., Nov. 6 /PRNewsw...g Administration (FDA), McNeil Consumer Healthcare...luntary recall of a limited number of product lots...bottles, with the distinctive red EZ-OPEN CAP. McN...uncharacteristic smell or taste associated with th...

(Date:11/6/2009)..., MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCall/...leading specialty pharmaceutical company, announce...hief executive officer, will provide an overview a...Suisse 18th Annual Healthcare Conference on Wednes...d Time. ,, This presentation will be webcast li...

Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8 SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9 McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2 Avalere Estimates Medicare Part D Donut Hole Will Be Obsolete in 2023 50579 1 Avalere Estimates Medicare Part D Donut Hole Will Be Obsolete in 2023 50579 2 Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 1 Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 2 Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 3 Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 4 Lung Cancer Alliance Praises Congresswoman Donna Christensen for Introduction of Legislation to Correct Healthcare Disparities 50569 1 Lung Cancer Alliance Praises Congresswoman Donna Christensen for Introduction of Legislation to Correct Healthcare Disparities 50569 2

[0] SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results [0] McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP [0] Watson to Present at Credit Suisse Healthcare Conference

...s, a division of Wyeth (NYSE: WYE ), announced to...A) has issued an approvable letter for,the first-i...e treatment of,adult patients with community-acqui...he FDA requested that Wyeth provide,additional ana...L for the,treatment of patients with CAP with illn...

...development in treatment-experi...Mune, Inc.,(Nasdaq: ITMN ) today announced that i...evaluating ITMN-191, designated R7227 at Roche (SW...interferon alpha-2a) and,Copegus(R) (ribavirin) in...patitis C virus (HCV) genotype 1 infection., Inte...

Other Medicine Technology:Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6 InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C 2 InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C 3 InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C 4

Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C

(Date:11/9/2009)...rchers find long-term risks, but not all agree , ...ing sinuses with a saline solution might have soot...ke you more prone to infections in the long run by..., "By washing the nose, we are removing the bad...e good mucus that contains the antimicrobial agent...

(Date:11/9/2009)... Industry leader readies its a...lly migrate to and reduce IT risk on Windows 7 and... plans with solution readiness. , ..., , , ,News Facts , As businesses ...indows 7 and Windows 2008 Server R2, Lumension , ...

(Date:11/9/2009)... NBC’s Today Show featur...ian, Dr. Jill Waibel on Friday Nov. 6th 2009, The... Berns after their first appearance on the Today S...d by Matt Lauer regarding their treatments by Dr. ...Pulse TotalFX laser. , (P...

(Date:11/9/2009)... This device is ideal for endu...t and is available at ShopCompex.com , ...09 -- Compex®, a brand of DJO Incorporated, a ...s, is pleased to announce the launch of the latest...Compex Sport Elite. The Sport Elite was designed t...

(Date:11/9/2009)... Vancouver Career College laun... Surrey, BC (Vocus) November 9...er College in Surrey are digging through their clo... Surrey citizens to do the same in order to help w...ay we focus on building a community here on campus...

Breaking Medicine News(10 mins):Health News:Sinus Rinses May Do More Harm Than Good 2 Health News:Sinus Rinses May Do More Harm Than Good 3 Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 2 Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 3 Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 4 Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 2 Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 3 Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 4 Health News:COMPEX Intoduces New Sport Elite Electrical Muscle Stimulation Unit 2 Health News:COMPEX Intoduces New Sport Elite Electrical Muscle Stimulation Unit 3 Health News:Surrey College Students Collect Clothing for Women and Children 2

[0] Sinus Rinses May Do More Harm Than Good [0] Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms [0] Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show [0] COMPEX Intoduces New Sport Elite Electrical Muscle Stimulation Unit [0] Surrey College Students Collect Clothing for Women and Children

...ificial heart was approved by the U.S. Food and Dr...al heart has been approved for patients with sever...plant. Under the FDA's Humanitarian Use Device... per year. The usage of this artificial heart is r...

... about 300 million poultry next month against bird...ls in the midst of large-scale criticism over the ...nced that the government plans of mass vaccination...rged Jakarta to give precedence for controlling th...

...em that could help in determining the condition of...do Silvio Nu?o Almirantearena has developed a new ...rt attack, brain stroke or high blood pressure, by...agnosis of the condition of the arterial system in...

...of Clinical Investigation and the September issue ... Monash University have reported that a new drug h...nd heart attacks by improving the blood flow in di... of the arteries. The finding is a significa...

... Zero after 9/11 are struggling with serious healt...to advocates.// "When we were needed on 9/11, no o...re anymore," said Lucelly Gil, who was present in ... necessary protection. "All of us who worked in th...

...t it has asked EU health authorities to re-examine...reatment Tarceva.// The European Committee for Me... rejected the Tarceva application. "People wi...ady been approved for this indication in the US," ...

Other Medicine News:Health News:First Implantable artificial heart gets FDA’s approva 2 Health News:Indonesia To Conduct Mass Vaccination Of Poultry 2 Health News:A New System Developed For Studying The Condition Of The Human Arterial System 2 Health News:A New Drug That Could Revolutionize Management Of Heart Disease 2

First Implantable artificial heart gets FDA’s approva Indonesia To Conduct Mass Vaccination Of Poultry A New System Developed For Studying The Condition Of The Human Arterial System A New Drug That Could Revolutionize Management Of Heart Disease Immigrants Who Responded After 9/11 Lack Health Care Roche Calls For Re-Examination Of Tarceva Data By EU Authorities

...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...

Medicine Products:

T-Cell Immunodeficiency Short Profile T-Cell Immunodeficiency Extended Profile T-Cell Clonality Assessment by Restriction Fragment Southern Blot Hybridization, Tissue T-Cell Clonality Screening Assay by PCR, Paraffin

( 5-9905 Investors: Amy Sullivan (617) ...)Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial,Health